−0.2 ILS
−73.32 M ILS
0.00 ILS
352.66 M
About PURPLE BIOTECH
Sector
CEO
Gil Efron
Headquarters
Rehovot
Website
Founded
1968
ISIN
IL0007650166
FIGI
BBG000JYS3Z9
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PPBT is 4.6 ILA — it has decreased by −6.12% in the past 24 hours. Watch PURPLE BIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange PURPLE BIOTECH stocks are traded under the ticker PPBT.
PPBT stock has fallen by −9.80% compared to the previous week, the month change is a −43.90% fall, over the last year PURPLE BIOTECH has showed a −87.89% decrease.
PPBT reached its all-time high on Oct 1, 2013 with the price of 74,100.0 ILA, and its all-time low was 4.7 ILA and was reached on Nov 18, 2024. View more price dynamics on PPBT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PPBT stock is 13.95% volatile and has beta coefficient of −0.51. Track PURPLE BIOTECH stock price on the chart and check out the list of the most volatile stocks — is PURPLE BIOTECH there?
Yes, you can track PURPLE BIOTECH financials in yearly and quarterly reports right on TradingView.
PPBT net income for the last quarter is −2.46 M ILS, while the quarter before that showed −8.96 M ILS of net income which accounts for 72.53% change. Track more PURPLE BIOTECH financial stats to get the full picture.
No, PPBT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 20.00 employees. See our rating of the largest employees — is PURPLE BIOTECH on this list?
Like other stocks, PPBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURPLE BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURPLE BIOTECH technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURPLE BIOTECH stock shows the sell signal. See more of PURPLE BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.